7:33AM Savient Pharma names rheumatology veteran Kenneth Bahrt CMO; effective August 1st (SVNT) 7.45 : Bahrt joins Savient from Genentech, recently acquired by Roche (RHHBY) where he served as Therapeutic Area Head for US Medical Affairs leading the medical affairs team for four marketed biological products and serving as the US medical lead on their Rheumatology Global Franchise Team.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.